Skip to content
Politically.com Search all
Menu

2026 · 1st Quarter (Jan 1 - Mar 31)

BRIGHT PATH LABS

Filed by BUCHANAN INGERSOLL & ROONEY PC.

Open official filing
Source: Lobbying Disclosure APIRecently refreshed. 2026-08-03 06:26:15 UTC.

Source-reported fields

Filing overview

Type
1st Quarter - Report
Posted
Apr 20, 2026
Income
$30,000.00
Expenses
Not reported
Filing UUID
76a0bfdb-48f4-4644-ad17-3b34c67acd7b
Termination date
Not reported

Literal source text

Lobbying issues and bill citations

HCR · Health Issues

Develop and execute a government relations strategy on issues relevant to Bright Path Labs.

PHA · Pharmacy

Develop and execute a government relations strategy on issues relevant to Bright Path Labs.

MED · Medical/Disease Research/Clinical Labs

Develop and execute a government relations strategy on issues relevant to Bright Path Labs.

MAN · Manufacturing

Develop and execute a government relations strategy on issues relevant to Bright Path Labs.

MMM · Medicare/Medicaid

Develop and execute a government relations strategy on issues relevant to Bright Path Labs.

DEF · Defense

Develop and execute a government relations strategy on issues relevant to Bright Path Labs.

Relationship and amount limits

Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.